Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients’ satisfaction

Palandri, Francesca; Bartoletti, Daniela; Giaquinta, S.; D'Ambrosio, Federica; Auteri, Giuseppe; Sutto, Emanuele; Catani, Lucia; Vianelli, Nicola; Cavo, Michèle

doi:10.1111/bjh.17208

Cited by 18 publications

(16 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reportedly, the use of teleconsultation improves access to healthcare services 17 and maintains high patient satisfaction, 18 19 even in times of a pandemic. In order to prepare and respond to the recurrent outbreaks of infectious diseases in the future, it is necessary to discuss the direction teleconsultation is taking.…”

Section: Discussionmentioning

confidence: 99%

Preliminary Results of Teleconsultations Temporarily Allowed during the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

Purpose During the COVID-19 pandemic, Korea has temporarily expanded coverage of teleconsultation to ensure access to essential health services. As a preliminary study, we investigated service utilization patterns and the characteristics of doctors and patients involved in these temporary teleconsultation services. Materials and Methods Using national health insurance claims data from February 23, 2020 to June 30, 2020 from the Health Insurance Review and Assessment Service, 228269875 cases were identified. Among them, 567390 cases that received teleconsultation services were included in our study. We performed descriptive analyses according to the types of healthcare institutions. Results In total, 6193 healthcare institutions provided teleconsultation. Of these, 5466 (88.3%) were clinics. Physicians providing teleconsultations were most likely to be doctors of internal medicine (34.0%) or pediatricians (7.0%) and based in the Seoul Metropolitan area (30.4%). In terms of patients undergoing teleconsultation, the most common major disease categories treated were circulatory system diseases (I00–I99). In a detailed analysis, hypertensive diseases (I10–I15) were the most common diagnoses, with a total of 88726 cases (15.6%), followed by diabetes mellitus at 60298 cases (10.6%). The proportion of Medical Aid recipients receiving teleconsultations was higher (9.5%) than other socioeconomic groups. Among all participants, 356622 cases (84.6%) were from a return visit, and 108838 cases (19.2%) received teleconsultation services without being prescribed drugs. Conclusion Temporarily allowed teleconsultation services were provided mostly to the following patients: 1) those scheduled for revisitation, 2) those with chronic diseases, and 3) those living in pandemic hotspots.

show abstract

Section: Discussionmentioning

confidence: 99%

Preliminary Results of Teleconsultations Temporarily Allowed during the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Compared to patients receiving a telephone contact, the patients who required in person visits were more frequently affected by MF, under active therapy and enrolled into a clinical trial. Although telemedicine resulted in an overall good level of patients' satisfaction, the lack of physical interaction was perceived as a strong limitation by all patients, emphasizing how much hematological care moves beyond the technical evaluation of blood tests, and instead involves a global patientdoctor relationship (24,25). Even in our study, 68.2% of patients (n=90) reported to have communicated with the caregiver with new means compared to the usual ones.…”

Section: Measurement Of Bsmentioning

confidence: 52%

Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study

et al. 2021

View full text Add to dashboard Cite

IntroductionThe Coronavirus disease 2019 (COVID-19) pandemic and the resulting social distancing, determined a reduction in access to care and limitations of individual freedom, with a consequent strong impact on quality of life (QoL), anxiety levels and medical management of onco-hematological people. In particular, in the case of patients with chronic myeloproliferative neoplasm (MPN), concern about SARS-CoV-2 infection added to the burden of symptoms (BS) which already weights on the QoL of these patients. We designed a cross-sectional survey in order to investigate the impact of the COVID-19 pandemic on status of anxiety, BS and QoL in MPN patients.MethodsWe analyzed the anxiety levels using the Zung Self-Rating Anxiety Scale (SAS); BS modifications were studied using the 18 items of the Myeloproliferative Neoplasm Symptom Assessment Form [MPN-SAF].Results132 people answered to the survey: 27 (20.4%) patients achieved a moderate to marked anxiety index value: this group described a greater worsening of symptoms than the rest of the cohort (p <0.0001). Women showed a higher level of anxiety than men (p = 0.01). A trend for lower level of anxiety was reported by patients who performed habitual physical activity (p = 0.06). A total of 98 (74.2%) patients described worsening of their symptoms during the quarantine period; 94 (71.2%) patients had postponed appointments or visits: they showed a significant worsening of their BS (p =0.01).ConclusionThis study first showed that the COVID-19 quarantine had a significant negative impact on the level of anxiety and BS in MPN patients. We identified female gender, absence of physical activity, the need for frequent visit to the hospital and the absence of a direct access to healthcare staff as the main factors associated to a higher anxiety index and worst BS.

show abstract

“…Behavior modification can reduce the transmission, prevent disease spread and contribute to release the overwhelmed health care system [22]. Telephone screening has been shown to be effective in cancer care as reported previously [23][24][25]. We have had an active telephone consultation facility since 2013.…”

Section: Plos Onementioning

confidence: 84%

Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka

et al. 2021

View full text Add to dashboard Cite

Background The Covid-19 pandemic has caused significant morbidity and mortality among patients with cancer. Most countries employed measures to prevent spread of Covid-19 infection which include shielding, quarantine, lockdown, travel restrictions, physical distancing and the use of personal protective equipment. This study was carried out to assess the change in patient attendance and the efficacy of newly implemented strategies to mitigate the impact of Covid-19 on services at the Lanka Hospital Blood Cancer Centre (LHBCC) in Colombo, Sri Lanka. Methodology Telephone consultation, infection control, personal protective measures and emergency admission policy were implemented with the aim of having a Covid-19 free ward and to prevent cross-infections. This descriptive cross-sectional study was conducted with 1399 patient episodes (in-patient care or day-case review). We analysed patients treated as in-patient as well as day-case basis between 01st April 2020 and 31st December 2020. Results There were 977 day-case based episodes and 422 in-patient based episodes. There was a 14% drop in episode numbers compared to same period in 2019. There was no cross infection and no patients with Covid-19 related symptoms or positive test results entered the LHBCC during the study period. Conclusion Services in blood cancer care were maintained to prevent late stage presentation and adverse outcome. Measures implemented to prevent Covid-19 were effective to allow continuation of treatment. This study highlights the importance of implementing strict protocols, clinical screening, use of appropriate personal protective equipment in delivering blood cancer care during the Covid-19 pandemic. This is the only documented study relating to outcome and successful applicability of measures to prevent spread of Covid-19 infection and maintaining services among blood cancer patients in Sri Lanka.

show abstract

Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients’ satisfaction

Cited by 18 publications

References 10 publications

Preliminary Results of Teleconsultations Temporarily Allowed during the COVID-19 Pandemic

Preliminary Results of Teleconsultations Temporarily Allowed during the COVID-19 Pandemic

Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study

Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka

Contact Info

Product

Resources

About